{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:36:40Z","timestamp":1785818200030,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,3,23]],"date-time":"2011-03-23T00:00:00Z","timestamp":1300838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"},{"start":{"date-parts":[[2011,3,23]],"date-time":"2011-03-23T00:00:00Z","timestamp":1300838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00406-011-0208-4","type":"journal-article","created":{"date-parts":[[2011,3,22]],"date-time":"2011-03-22T21:38:15Z","timestamp":1300829895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["EEG alterations during treatment with olanzapine"],"prefix":"10.1007","volume":"261","author":[{"given":"Detlef","family":"Degner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Nitsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckart","family":"R\u00fcther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Reulbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,23]]},"reference":[{"key":"208_CR1","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","volume":"63","author":"PB Jones","year":"2006","unstructured":"Jones PB, Barnes TR, Davies L et al (2006) Randomized controlled trial of the effect on quality of life of second- vs. first-generation antipsychotic drugs in schizophrenia: cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1). Arch Gen Psychiatry 63:1079\u20131087","journal-title":"Arch Gen Psychiatry"},{"key":"208_CR2","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa051688","volume":"353","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA, Stroup TS, McEvoy JP et al (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353:1209\u20131223","journal-title":"N Engl J Med"},{"key":"208_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","volume":"373","author":"S Leucht","year":"2009","unstructured":"Leucht S, Corves C, Arbter D et al (2009) Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 373:31\u201341","journal-title":"Lancet"},{"key":"208_CR4","doi-asserted-by":"crossref","unstructured":"Komossa K, Rummel-Kluge C, Hunger H, et al (2009) Olanzapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev CD006654","DOI":"10.1002\/14651858.CD006627.pub2"},{"key":"208_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/BF02245449","volume":"114","author":"C Haring","year":"1994","unstructured":"Haring C, Neudorfer C, Schwitzer J et al (1994) EEG alterations in patients treated with clozapine in relation to plasma levels. Psychopharmacology (Berl) 114:97\u2013100","journal-title":"Psychopharmacology (Berl)"},{"key":"208_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1176\/appi.ajp.159.1.109","volume":"159","author":"F Centorrino","year":"2002","unstructured":"Centorrino F, Price BH, Tuttle M et al (2002) EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry 159:109\u2013115","journal-title":"Am J Psychiatry"},{"key":"208_CR7","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/hup.537","volume":"18","author":"BL Amann","year":"2003","unstructured":"Amann BL, Pogarell O, Mergl R et al (2003) EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects. Hum Psychopharmacol 18:641\u2013646","journal-title":"Hum Psychopharmacol"},{"key":"208_CR8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0006-3223(96)00298-3","volume":"42","author":"O Freudenreich","year":"1997","unstructured":"Freudenreich O, Weiner RD, McEvoy JP (1997) Clozapine-induced electroencephalogram changes as a function of clozapine serum levels. Biol Psychiatry 42:132\u2013137","journal-title":"Biol Psychiatry"},{"key":"208_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1055\/s-2004-818989","volume":"37","author":"A Gross","year":"2004","unstructured":"Gross A, Joutsiniemi SL, Rimon R, Appelberg B (2004) Clozapine-induced QEEG changes correlate with clinical response in schizophrenic patients: a prospective, longitudinal study. Pharmacopsychiatry 37:119\u2013122","journal-title":"Pharmacopsychiatry"},{"key":"208_CR10","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1345\/aph.18062","volume":"32","author":"RC Silvestri","year":"1998","unstructured":"Silvestri RC, Bromfield EB, Khoshbin S (1998) Clozapine-induced seizures and EEG abnormalities in ambulatory psychiatric patients. Ann Pharmacother 32:1147\u20131151","journal-title":"Ann Pharmacother"},{"key":"208_CR11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1176\/jnp.6.3.250","volume":"6","author":"J Welch","year":"1994","unstructured":"Welch J, Manschreck T, Redmond D (1994) Clozapine-induced seizures and EEG changes. J Neuropsychiatry Clin Neurosci 6:250\u2013256","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"Suppl 10","key":"208_CR12","first-page":"13","volume":"58","author":"CM Beasley Jr","year":"1997","unstructured":"Beasley CM Jr, Tollefson GD, Tran PV (1997) Safety of olanzapine. J Clin Psychiatry 58(Suppl 10):13\u201317","journal-title":"J Clin Psychiatry"},{"key":"208_CR13","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1176\/appi.ajp.159.8.1439","volume":"159","author":"M Fink","year":"2002","unstructured":"Fink M (2002) EEG changes with antipsychotic drugs. Am J Psychiatry 159:1439 (discussion 1439)","journal-title":"Am J Psychiatry"},{"key":"208_CR14","first-page":"244","volume":"25","author":"H Jasper","year":"1958","unstructured":"Jasper H (1958) Progress and problems in brain research. J Mt Sinai Hosp NY 25:244\u2013253","journal-title":"J Mt Sinai Hosp NY"},{"key":"208_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1055\/s-2000-7976","volume":"33","author":"A Schuld","year":"2000","unstructured":"Schuld A, Kuhn M, Haack M et al (2000) A comparison of the effects of clozapine and olanzapine on the EEG in patients with schizophrenia. Pharmacopsychiatry 33:109\u2013111","journal-title":"Pharmacopsychiatry"},{"key":"208_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s002130100861","volume":"158","author":"D Hubl","year":"2001","unstructured":"Hubl D, Kleinlogel H, Frolich L et al (2001) Multilead quantitative electroencephalogram profile and cognitive evoked potentials (P300) in healthy subjects after a single dose of olanzapine. Psychopharmacology (Berl) 158:281\u2013288","journal-title":"Psychopharmacology (Berl)"},{"key":"208_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1023\/B:BRAT.0000032866.20058.5c","volume":"16","author":"K Yamada","year":"2004","unstructured":"Yamada K, Isotani T, Irisawa S et al (2004) EEG Global field power spectrum changes after a single dose of atypical antipsychotics in healthy volunteers. Brain Topogr 16:281\u2013285","journal-title":"Brain Topogr"},{"key":"208_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s002130000426","volume":"150","author":"F Pillmann","year":"2000","unstructured":"Pillmann F, Schlote K, Broich K, Marneros A (2000) Electroencephalogram alterations during treatment with olanzapine. Psychopharmacology (Berl) 150:216\u2013219","journal-title":"Psychopharmacology (Berl)"},{"key":"208_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1515\/REVNEURO.2010.21.4.289","volume":"21","author":"MA Nitsche","year":"2010","unstructured":"Nitsche MA, Monte-Silva K, Kuo MF, Paulus W (2010) Dopaminergic impact on cortical excitability in humans. Rev Neurosci 21:289\u2013298","journal-title":"Rev Neurosci"},{"key":"208_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/0269881105056657","volume":"20","author":"A Wichniak","year":"2006","unstructured":"Wichniak A, Szafranski T, Wierzbicka A, Waliniowska E, Jernajczyk W (2006) Electroencephalogram slowing, sleepiness and treatment response in patients with schizophrenia during olanzapine treatment. J Psychopharmacol 20:80\u201385","journal-title":"J Psychopharmacol"},{"key":"208_CR21","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1345\/aph.18399","volume":"33","author":"RJ Wyderski","year":"1999","unstructured":"Wyderski RJ, Starrett WG, Abou-Saif A (1999) Fatal status epilepticus associated with olanzapine therapy. Ann Pharmacother 33:787\u2013789","journal-title":"Ann Pharmacother"},{"issue":"Suppl 1","key":"208_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1528-1167.2006.00655.x","volume":"47","author":"NB Fountain","year":"2006","unstructured":"Fountain NB, Freeman JM (2006) EEG is an essential clinical tool: pro and con. Epilepsia 47(Suppl 1):23\u201325","journal-title":"Epilepsia"},{"key":"208_CR23","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1528-1167.2006.00434.x","volume":"47","author":"HL Kim","year":"2006","unstructured":"Kim HL, Donnelly JH, Tournay AE, Book TM, Filipek P (2006) Absence of seizures despite high prevalence of epileptiform EEG abnormalities in children with autism monitored in a tertiary care center. Epilepsia 47:394\u2013398","journal-title":"Epilepsia"},{"key":"208_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00406-008-0854-3","volume":"259","author":"U Gschwandtner","year":"2009","unstructured":"Gschwandtner U, Pflueger MO, Semenin V et al (2009) EEG: a helpful tool in the prediction of psychosis. Eur Arch Psychiatry Clin Neurosci 259:257\u2013262","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"Suppl 2","key":"208_CR25","doi-asserted-by":"publisher","first-page":"S227","DOI":"10.1007\/s00406-009-0054-9","volume":"259","author":"A Brocheler","year":"2009","unstructured":"Brocheler A, Bergmann F, Schneider F (2009) Models of mental health care in psychiatry across sectoral borders. Eur Arch Psychiatry Clin Neurosci 259(Suppl 2):S227\u2013S232","journal-title":"Eur Arch Psychiatry Clin Neurosci"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-011-0208-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-011-0208-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00406-011-0208-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-011-0208-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T05:40:32Z","timestamp":1630474832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-011-0208-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,23]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["208"],"URL":"https:\/\/doi.org\/10.1007\/s00406-011-0208-4","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,23]]},"assertion":[{"value":"7 May 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"483"}}